all report title image

PET CANCER THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Pet Cancer Therapeutics Market, By Therapy Type (Chemotherapy, Targeted Therapy, Combination Therapy, and Immunotherapy), By Pet Type (Cat, Dog, and Horse), By Mode of Administration (Oral, Intravenous, and Topical), By Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In: 25 May, 2026
  • Code: CMI1284
  • Page number: 250+
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026 - 2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Therapy Type
      • Market Snippet, By Pet Type
      • Market Snippet, By Mode of Administration
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Key Highlights
    • Pipeline Analysis
    • Regulatory Guidelines
    • Initiatives for Prevention of Pet Cancer
    • Approved Targeted Therapies for Pet Cancer
    • Epidemiology
  4. Global Pet Cancer Therapeutics Market, By Therapy Type, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Chemotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Targeted Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Combination Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Immunotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  5. Global Pet Cancer Therapeutics Market, By Pet Type, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Cat
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Dog
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Horse
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  6. Global Pet Cancer Therapeutics Market, By Mode of Administration, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Intravenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  7. Global Pet Cancer Therapeutics Market, By Application, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Lymphoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Mast Cell Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Melanoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Mammary and Squamous Cell Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  8. Global Pet Cancer Therapeutics Market, By Region, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • North America
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Aratana Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • AB Science
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Boehringer Ingelheim International GmbH
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Zenoaq
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Morphogenesis, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • VetDC, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Karyopharm Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Rhizen Pharmaceuticals SA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Regeneus Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Oasmia Pharmaceuticals AB
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Zoetis
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  10. Section

    • References
    • Research Methodology
    • About us and Sales Contact
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.